American Journal of Medical Case Reports. 2015, 3(6), 174-176
DOI: 10.12691/ajmcr-3-6-7
Open AccessCase Report
HAMZA HASHMI MD1, and UMAYR AZIMI MD1
1Grand Rapids Medical Education Partners
Pub. Date: May 19, 2015
Cite this paper:
HAMZA HASHMI MD and UMAYR AZIMI MD. HIT BY HEPARIN: A Rare Case of Late Onset Heparin Induced Thrombocytopenia. American Journal of Medical Case Reports. 2015; 3(6):174-176. doi: 10.12691/ajmcr-3-6-7
Abstract
Heparin induced thrombocytopenia is a rare complication of heparin therapy that usually occurs within initial 5 to 10 days of heparin exposure. We present a rare case of delayed onset heparin induced thrombocytopenia that occurred one week after cessation.Keywords:
heparin induced thrombocytopenia argatroban coronary artery bypass grafting serotonin release assay
This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit
http://creativecommons.org/licenses/by/4.0/
References:
[1] | Warkentin TE. Think of HIT. Hematology Am Soc Hematol Educ Program 2006:408-414. |
|
[2] | Alving BM. How I treat heparin-induced thrombocytopenia and thrombosis. Blood2003; 101(1):31-37. |
|
[3] | Warkentin TE. Clinical presentation of heparin-induced thrombocytopenia. Semin Hematol 1998;35 4 suppl:9-16. |
|
[4] | Crowther MA, Cook DJ, Albert M, et al. The 4Ts scoring system for heparin-induced thrombocytopenia in medical-surgical intensive care unit patients. J Crit Care2010;25(2):287-293. |
|
[5] | Denys B, Stove V, Philippe J, Devreese K. A clinical-laboratory approach contributing to a rapid and reliable diagnosis of heparin-induced thrombocytopenia. Thromb Res2008;123(1):137-145. |
|
[6] | Lewis BE, Aranda C, Lewis M, Hoppensteadt D, Walenga JM, Fareed J. Unlike heparins newer oral anticoagulants do not interact with HIT antibodies and maybe useful in the long-term anticoagulant management of heparin compromised patients [abstracts]. Am Soc Hematol Educ Program 2011; 118(21). |
|
[7] | Potzsch B, Klovekorn WP, Madlener K. Use of heparin during cardiopulmonary bypass in patients with a history of heparin-induced thrombocytopenia. N Engl J Med2000; 343(7):515. |
|